Here are four things to know:
1. The GI sealant is designed to minimize staple-line leakage in gastrointestinal resection procedures.
2. The FDA trial will be a multi-center, multinational, randomized, double-arm, single-blind study.
3. There will be study sites in both the Unites States and Europe.
4. The LifeSeal Surgical Sealant Kit has received the CE Mark.
More articles on GI/endoscopy:
Surveillance endoscopy improves esophageal cancer outcomes in Barrett’s esophagus patients: 3 insights
Small bowel resection inpatient costs total $28.5k & 7 more statistics
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes
